clinical trial · NCT07616128
Study of EVO756 in Adults With Migraine
MigraineEVO756, Dose 1EVO756, Dose 2Placebo
brief summary
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
started
Jul 29, 2026
primary completion
Oct 1, 2027
completion
Nov 1, 2027
last updated
Oct 2, 2026
official title
A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol